MAP PHARMACEUTICALS, INC. Operating Expenses
MAP PHARMACEUTICALS, INC. reported Operating Expenses of $13.50 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. operating expenses for the quarter ending 2012-09-30 was $13.50M, a 6.99% increase year-over-year.
- MAP PHARMACEUTICALS, INC. operating expenses for the quarter ending 2012-06-30 was $14.17M, a 17.56% increase year-over-year.
- MAP PHARMACEUTICALS, INC. operating expenses for the quarter ending 2012-03-31 was $18.87M, a 14.99% increase year-over-year.
- MAP PHARMACEUTICALS, INC. operating expenses for the quarter ending 2011-12-31 was $14.64M, a 6.57% increase year-over-year.
- MAP PHARMACEUTICALS, INC. operating expenses for fiscal 2011 was $55.72M, a 4.18% increase from fiscal 2010.
- MAP PHARMACEUTICALS, INC. operating expenses for fiscal 2010 was $53.49M, a 12.51% decline from fiscal 2009.
- MAP PHARMACEUTICALS, INC. operating expenses for fiscal 2009 was $61.13M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 96 month | Operating Expenses 99 month | Operating Expenses 102 month | Operating Expenses 105 month | Operating Expenses 108 month | Operating Expenses 111 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $13.50M 10-Q · filed 2012-11-06 | $27.67M derived: sum of 2 quarters · filed 2012-11-06 | $46.54M 10-Q · filed 2012-11-06 | $61.18M derived: sum of 4 quarters · filed 2012-11-06 | $382.65M 10-Q · filed 2012-11-06 | |||||
| 2012-06-30 | $14.17M 10-Q · filed 2012-07-27 | $33.04M 10-Q · filed 2012-07-27 | $47.69M derived: sum of 3 quarters · filed 2012-07-27 | $60.30M derived: sum of 4 quarters · filed 2012-11-06 | $369.15M 10-Q · filed 2012-07-27 | |||||
| 2012-03-31 | $18.87M 10-Q · filed 2012-05-08 | $33.51M derived: sum of 2 quarters · filed 2012-05-08 | $46.13M derived: sum of 3 quarters · filed 2012-11-06 | $58.18M derived: sum of 4 quarters · filed 2012-11-06 | $354.98M 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | $14.64M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $27.26M derived: sum of 2 quarters · filed 2012-11-06 | $39.31M derived: sum of 3 quarters · filed 2012-11-06 | $55.72M 10-K · filed 2012-03-30 | $336.11M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | $12.62M 10-Q · filed 2012-11-06 | $24.67M derived: sum of 2 quarters · filed 2012-11-06 | $41.08M 10-Q · filed 2012-11-06 | $54.82M derived: sum of 4 quarters · filed 2012-11-06 | $321.46M 10-Q/A · filed 2012-03-30 | |||||
| 2011-06-30 | $12.05M 10-Q · filed 2012-07-27 | $28.47M 10-Q · filed 2012-07-27 | $42.20M derived: sum of 3 quarters · filed 2012-07-27 | $56.13M derived: sum of 4 quarters · filed 2012-07-27 | $308.85M 10-Q/A · filed 2012-03-30 | |||||
| 2011-03-31 | $16.41M 10-Q · filed 2012-05-08 | $30.15M derived: sum of 2 quarters · filed 2012-05-08 | $44.08M derived: sum of 3 quarters · filed 2012-05-08 | $56.23M derived: sum of 4 quarters · filed 2012-05-08 | ||||||
| 2010-12-31 | $13.74M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $27.67M derived: sum of 2 quarters · filed 2012-03-30 | $39.82M derived: sum of 3 quarters · filed 2012-03-30 | $53.49M 10-K · filed 2012-03-30 | ||||||
| 2010-09-30 | $13.93M 10-Q/A · filed 2012-03-30 | $26.08M derived: sum of 2 quarters · filed 2012-03-30 | $39.75M 10-Q/A · filed 2012-03-30 | |||||||
| 2010-06-30 | $12.15M 10-Q/A · filed 2012-03-30 | $25.82M 10-Q/A · filed 2012-03-30 | ||||||||
| 2009-12-31 | $61.13M 10-K · filed 2012-03-30 |